Shanghai's SARI Pays $359M for Italian Cancer Biopharma NMS Post author:Sam Post published:December 28, 2017 Post category:BioPharma The parts expect the closing in the first quarter 2018. Source: BioSpace You Might Also Like A Novel, Quantitative Immunohistochemistry Method Enabled By BioGenex, Inc. IHC System February 16, 2017 Kaleo Release: Pharma Announces U.S. Availability And Pricing To Patients Of AUVI-Q (Epinephrine Injection, USP) Auto-Injector, For Life-Threatening Allergic Reactions January 18, 2017 DURECT Stock Plunges as Pain Med Fails Phase III October 19, 2017
A Novel, Quantitative Immunohistochemistry Method Enabled By BioGenex, Inc. IHC System February 16, 2017
Kaleo Release: Pharma Announces U.S. Availability And Pricing To Patients Of AUVI-Q (Epinephrine Injection, USP) Auto-Injector, For Life-Threatening Allergic Reactions January 18, 2017
